DC/MM Fusion Vaccine With BCMA CAR-T in R/R MM

Clinical trial NCT07377435 · RECRUITING

Trial details

NCT number: NCT07377435
Sponsor: David Avigan
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma Refractory Multiple Myeloma Relapse Multiple Myeloma

Start date: 2026-01-30
Primary completion: 2028-03-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.